首页> 美国卫生研究院文献>BMC Cancer >TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

【2h】

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

机译：TROG 15.03局灶性消融立体定向放射外科手术治疗肾脏癌的第二阶段临床试验-FASTRACK II

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundStereotactic ablative body radiotherapy (SABR) is a non-invasive alternative to surgery to control primary renal cell cancer (RCC) in patients that are medically inoperable or at high-risk of post-surgical dialysis. The objective of the FASTRACK II clinical trial is to investigate the efficacy of SABR for primary RCC.

机译：背景立体定向消融身体放疗（SABR）是在医学上无法手术或术后透析高危患者中控制原发性肾细胞癌（RCC）的外科手术的一种非侵入性替代方法。 FASTRACK II临床试验的目的是研究SABR对原发性RCC的疗效。

著录项

期刊名称 BMC Cancer
作者
Shankar Siva; Brent Chesson; Mathias Bressel; David Pryor; Braden Higgs; Hayley M. Reynolds; Nicholas Hardcastle; Rebecca Montgomery; Ben Vanneste; Vincent Khoo; Jeremy Ruben; Eddie Lau; Michael S. Hofman; Richard De Abreu Lourenco; Swetha Sridharan; Nicholas R. Brook; Jarad Martin; Nathan Lawrentschuk; Tomas Kron; Farshad Foroudi;
展开▼
作者单位

展开▼
年(卷),期 2018(18),-1
年度 2018
页码 1030
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
SBRT SABR RCC Metastases Kidney Adrenal Ablation Nephrectomy;

机译：SBRT;SABR;RCC;转移;肾脏;肾上腺;消融;肾切除术;

相似文献

外文文献
中文文献
专利

1. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II [J] . Shankar Siva, Brent Chesson, Mathias Bressel, BMC Cancer . 2018,第1期

机译：TROG 15.03局灶性消融立体定向放射外科手术治疗肾脏癌的第二阶段临床试验-FASTRACK II
2. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II [J] . Shankar Siva, Brent Chesson, Mathias Bressel, BMC Cancer . 2018,第1期

机译：TROG 15.03局灶性消融立体定向放射外科手术治疗肾脏癌的第二阶段临床试验-FASTRACK II
3. A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II) [J] . Shankar Siva, Tomas Kron, Mathias Bressel, BMC Cancer . 2016,第1期

机译：立体定向消融分割放疗与放射外科治疗肺部低位转移瘤的随机II期试验（TROG 13.01 SAFRON II）
4. Clinical studies of SP1049C, a polymer based anthracycline effective against drug resistant tumors. Results of phase II trial and pivotal phase Ⅲ program in upper gastrointestinal cancer indications [C] . Valery Alakhov Controlled Release Society Annual Meeting and Exposition . 2007

机译：SP1049C的临床研究，一种基于聚合物的蒽环类药物可有效抵抗耐药性肿瘤。上消化道癌适应症的II期试验和关键性III期试验结果
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II) [O] . Shankar Siva, Tomas Kron, Mathias Bressel, 2016

机译：立体定向消融分级放疗与放射外科治疗肺部低位转移瘤的随机II期试验（TROG 13.01 SAFRON II）
7. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II [O] . Shankar Siva, Brent Chesson, Mathias Bressel, 2018

机译：Trog15.03期II期临床试验肾脏癌癌癌的临床试验 - Fastrack II

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

摘要

著录项

相似文献

相关主题

期刊订阅